Keratoconjunctival Protecting Agent, Or Keratoconjunctival Disorder Inhibiting Agent

Patent No. EP2783689 (titled "Keratoconjunctival Protecting Agent, Or Keratoconjunctival Disorder Inhibiting Agent") was filed by Otsuka Pharmaceutical Factory on Nov 22, 2012. The application was issued on Sep 25, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BITOPJun 25, 2020SCHNEIDERS & BEHRENDT BOCHUM

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2783689

OTSUKA PHARMACEUTICAL FACTORY
Application Number
EP12851333A
Filing Date
Nov 22, 2012
Status
Opposition Rejected
Mar 4, 2022
Publication Date
Sep 25, 2019